P
P Renzi
Publications - 4
Citations - 1450
P Renzi is an academic researcher. The author has contributed to research in topics: Randomized controlled trial & COPD. The author has an hindex of 4, co-authored 4 publications receiving 1396 citations.
Papers
More filters
Journal ArticleDOI
Reduction of Hospital Utilization in Patients With Chronic Obstructive Pulmonary Disease: A Disease-Specific Self-management Intervention
Jean Bourbeau,Marcel Julien,François Maltais,Michel Rouleau,Alain Beaupré,Raymond Bégin,P Renzi,Diane Nault,Elizabeth M. Borycki,Kevin Schwartzman,Ravinder Singh,Jean Paul Collet +11 more
TL;DR: A continuum of self-management for COPD patients provided by a trained health professional can significantly reduce the utilization of health care services and improve health status.
Journal ArticleDOI
Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention
Jean Bourbeau,Marcel Julien,François Maltais,Michel Rouleau,A Beaupre,Bégin R,P Renzi,Diane Nault,Elizabeth M. Borycki,Kevin Schwartzman,R Singh,Jean-Paul Collet,Susan Tiukinhoy,Carolyn L. Rochester +13 more
TL;DR: A continuum of self-management for COPD patients provided by a trained health professional can significantly reduce the utilization of health care services and improve health status.
Journal ArticleDOI
Self-management reduces both short- and long-term hospitalisation in COPD.
Gadoury Ma,Kevin Schwartzman,Michel Rouleau,François Maltais,Marcel Julien,A Beaupre,P Renzi,Bégin R,Diane Nault,Jean Bourbeau +9 more
TL;DR: Patients with chronic obstructive pulmonary disease who received educational intervention with supervision and support based on disease-specific self-management maintained a significant reduction in hospitalisations after a 2-year period.
Journal ArticleDOI
Economic Impact of Using an Immunostimulating Agent to Prevent Severe Acute Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
Jean-Paul Collet,Thierry Ducruet,Seema Haider,Stan Shapiro,Ann Robinson,P Renzi,André-Pierre Contandriopoulos,Pierre Ernst +7 more
TL;DR: Given the high prevalence of chronic obstructive pulmonary disease worldwide and the high cost of acute exacerbations, immunostimulants may become a key element in the improved control of this condition.